Possible reasons for group effect [Design Issues]

posted by GM – India, 2019-07-23 06:23 (635 d 16:34 ago) – Posting: # 20433
Views: 2,461

Hi Helmut and ElMaestro,

Thanks for reply. It helps me a lot.

I have seen one FDA BE review (see link) regarding group effect. Please see page 6 (Reviewer’s Comments) and page 52 (control document).

Here agency is asking for the BE of any one of the group, if group-by-treatment interaction is significant (p<0.05). Is it possible in studies conducted on HVD?

Please provide your thoughts on the same.

Best Regards,

Complete thread:

 Admin contact
21,419 posts in 4,475 threads, 1,508 registered users;
online 16 (0 registered, 16 guests [including 4 identified bots]).
Forum time: Sunday 22:57 CEST (Europe/Vienna)

Nothing fails like success because you do not learn anything from it.
The only thing we ever learn from is failure.
Success only confirms our superstitions.    Kenneth E. Boulding

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz